
Orwicef Ls 2.5mg/30mg/50mg Syrup
Marketer
Orwin Biotech Pvt. Ltd.
Salt Composition
Levosalbutamol (2.5mg) + Ambroxol (30mg) + Guaifenesin (50mg)
Overview Orwicef Ls 2.5mg/30mg/50mg Syrup
Lysomucil Cough Syrup (2.5mg/30mg/50mg) effectively manages coughs accompanied by phlegm. It facilitates mucus clearance from the nasal passages, trachea, and lungs, easing expectoration. This syrup also alleviates symptoms such as nasal discharge, sneezing, itching, and eye watering. Administer Lysomucil Cough Syrup with or without food, following your physician's prescribed dosage and duration. Your individual dose will be determined by your condition and response to treatment. Continue the medication as directed; premature discontinuation may lead to symptom recurrence and potential worsening of your condition. Inform your healthcare provider of all other medications you are using, as interactions may occur. Common side effects include lightheadedness, nausea, altered taste perception, loose stools, cephalgia, and skin rashes. These are typically transient and resolve spontaneously. Report any concerning side effects immediately to your doctor. Drowsiness is a possible effect; refrain from driving or activities demanding concentration until its impact is known. Alcohol consumption should be avoided due to potential exacerbation of drowsiness. Self-medication and sharing this medication are strongly discouraged. Adequate hydration is recommended during treatment. Consult your doctor before use if you are pregnant, intend to become pregnant, or are breastfeeding, or if you have kidney or liver impairment, to ensure appropriate dosage.
Uses of Orwicef Ls 2.5mg/30mg/50mg Syrup
Productive cough
Major Benefits of Orwicef Ls 2.5mg/30mg/50mg Syrup:
Administer this medication precisely as prescribed by your physician, adhering to the dosage and treatment schedule. Always consult the product label for detailed instructions prior to consumption. Accurate measurement should be achieved using a calibrated dispensing device; oral administration is recommended. Ensure thorough shaking before each dose. Orwicef Ls 2.5mg/30mg/50mg Syrup can be ingested with or without food; however, consistent timing is preferable.
How to use Orwicef Ls 2.5mg/30mg/50mg Syrup:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Always consult the product label for complete instructions prior to use. Accurate measurement should be achieved using a measuring cup; oral ingestion is recommended. Ensure thorough shaking before each dose. Orwicef Ls 2.5mg/30mg/50mg Syrup can be consumed with or without food, however, consistent daily timing is preferable.
How Orwicef Ls 2.5mg/30mg/50mg Syrup works:
Each 2.5mg/30mg/50mg dose of Orwicef LS Syrup combines levosalbutamol, ambroxol, and guaifenesin to alleviate coughs productive of mucus. Levosalbutamol, a bronchodilator, opens airways by relaxing airway muscles. Ambroxol, a mucolytic agent, thins phlegm, facilitating expectoration. Guaifenesin, an expectorant, reduces phlegm viscosity, aiding its clearance from the respiratory tract.
SAFETY ADVICE
AlcoholUNSAFE
Combining Orwicef LS 2.5mg/30mg/50mg Syrup and alcohol can lead to significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Orwicef LS 2.5mg/30mg/50mg Syrup during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Orwicef LS 2.5mg/30mg/50mg Syrup safely. Available human data indicate minimal infant risk associated with this medication.
DrivingUNSAFE
Driving ability may be impaired by the side effects of Orwicef LS 2.5mg/30mg/50mg Syrup.
KidneyCAUTION
Patients with kidney impairment should use Orwicef LS 2.5mg/30mg/50mg Syrup cautiously. Dosage modification may be necessary; physician consultation is advised. Data regarding Orwicef LS 2.5mg/30mg/50mg Syrup use in such patients is limited.
LiverCAUTION
Patients with liver impairment should use Orwicef Ls 2.5mg/30mg/50mg Syrup cautiously, potentially requiring dosage modification. Physician consultation is recommended, as data on its use in such cases is limited.
What if you forget to take Orwicef Ls 2.5mg/30mg/50mg Syrup :
Should you forget a dose of Orwicef Ls 2.5mg/30mg/50mg Syrup, administer it promptly. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Orwicef Ls 2.5mg/30mg/50mg Syrup
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Breathing |
